TWNK
protein-codingtwinkle mtDNA helicase, the group of DNA helicases
Gene summary
This gene encodes a hexameric DNA helicase which unwinds short stretches of double-stranded DNA in the 5' to 3' direction and, along with mitochondrial single-stranded DNA binding protein and mtDNA polymerase gamma, is thought to play a key role in mtDNA replication. The protein localizes to the mitochondrial matrix and mitochondrial nucleoids. Mutations in this gene cause infantile onset spinocerebellar ataxia (IOSCA) and progressive external ophthalmoplegia (PEO) and are also associated with several mitochondrial depletion syndromes. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Aug 2009]
- IOSCA
- C10orf2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0012241
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012241
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014504
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014504
Submitter: ClinGen
TWNK was first reported in relation to autosomal recessive Perrault Syndrome in 2005 (Nikali et al., PMID: 16135556). This condition is characterized by childhood-onset, progressive, and moderate-to-profound hearing loss, as well as ocular anomalies (such as nystagmus and ophthalmoplegia); ataxia; hypotonia; neuropathy; seizures; brain structural anomalies (including cerebellar atrophy); demyelination; and, in females, amenorrhea/gonadal dysgenesis. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity, Perrault Syndrome (OMIM: 616138) and Mitochondrial DNA Depletion Syndrome (OMIM: 271245). However, due to a different inheritance pattern and phenotypic variability the following disease assertion was split from the other two assertions: Progressive External Ophthalmoplegia (OMIM: 606075). The split curation for autosomal dominant Progressive External Ophthalmoplegia will be curated separately. 25 variants (missense, frameshift, nonsense, and splicing) that have been reported in over 20 probands in 11 publications (PMIDs: 16135556, 24102492, 24816431, 25355836, 26920903, 26970254, 27551684, 28178980, 31455392, 32281099, 39780253) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse models; gEAR database expression; PMID: 16301523). Mouse models of TWNK missense and duplication mutants indicate that mutants have altered TWNK expression, mitochondrial degradation, and run longer distances in the cage wheel study, compared to the wild-type. Expression level evidence shows strong cochlear expression. In summary, there is definitive evidence supporting the relationship between TWNK and autosomal recessive Perrault Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0010060
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010060
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018197
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017312
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008003
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010060
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: Biochemical
Rationale: Individuals may have biochemical manifestations, including fasting hypoglycemia responsive to glucose therapy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TWNK variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021830.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 144 | 156 | |||
| missense | 17 | 50 | 302 | 16 | 1 | 386 |
| nonsense | 5 | 10 | 15 | |||
| start loss | 0 | |||||
| frameshift | 12 | 6 | 4 | 22 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 35 | 66 | 319 | 160 | 1 | 581 |
Highest pathogenic variant AF is 0.00011833469
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068602.2 | 5 | MANE Select | |
| Ensembl | ENSP00000309595.2 | 5 | MANE Select | |
| RefSeq | NP_001157284.1 | 4 | Standard | |
| RefSeq | NP_001157285.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mitochondrial biogenesis
Biological Process
- mitochondrial DNA replication
- DNA unwinding involved in DNA replication
- mitochondrial transcription
- mitochondrion organization
- protein hexamerization
Molecular Function
- protease binding
- single-stranded DNA binding
- ATP binding
- 5'-3' DNA helicase activity
Cellular Component
- mitochondrial matrix
- mitochondrial nucleoid
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000311916
- Coding exons
- 5
- Length
- 7035
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125748
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.61 | 301 | 390 | 0.771 | 0.0000268 | 4423 |
| Missense (PolyPhen) | 36 | 88.758 | 0.4056 | 1095 | ||
| Synonymous | -0.617 | 166 | 156 | 1.06 | 0.00000928 | 1464 |
| Loss of Function | 3.42 | 10 | 30.3 | 0.330 | 0.00000258 | 258 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in mitochondrial DNA (mtDNA) metabolism. Could function as an adenine nucleotide-dependent DNA helicase. Function inferred to be critical for lifetime maintenance of mtDNA integrity. In vitro, forms in combination with POLG, a processive replication machinery, which can use double-stranded DNA (dsDNA) as template to synthesize single-stranded DNA (ssDNA) molecules. May be a key regulator of mtDNA copy number in mammals. {ECO:0000269|PubMed:15167897}.;
- Disease
- DISEASE: Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]: A severe disease associated with mitochondrial dysfunction. Some patients are affected by progressive atrophy of the cerebellum, brain stem, the spinal cord, and sensory axonal neuropathy. Clinical features include hypotonia, athetosis, ataxia, ophthalmoplegia, sensorineural hearing deficit, sensory axonal neuropathy, epileptic encephalopathy and female hypogonadism. In some individuals liver dysfunction and multi- organ failure is present. {ECO:0000269|PubMed:16135556, ECO:0000269|PubMed:17722119, ECO:0000269|PubMed:17921179, ECO:0000269|PubMed:19853444, ECO:0000269|PubMed:22353293}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Perrault syndrome 5 (PRLTS5) [MIM:616138]: A form of Perrault syndrome, a sex-influenced disorder characterized by sensorineural deafness in both males and females, and ovarian dysgenesis in females. Affected females have primary amenorrhea, streak gonads, and infertility, whereas affected males show normal pubertal development and are fertile. {ECO:0000269|PubMed:25355836}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- RVIS EVS
- -0.78
- RVIS percentile EVS
- 12.97
Essentials
- Essential (gene trap)
- N